Formosa Pharmaceuticals and Saval Corporation Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain#Formosa #Pharmaceuticals #Saval #Corporation #Announce #Licensing #Agreement #Clobetasol #Propionate #Ophthalmic #Suspension #Treatment #PostOperative #Inflammation #Pain